USANA Health Sciences (USNA) Tops Q3 EPS by 7c; offers FY24 guidance

Go back to USANA Health Sciences (USNA) Tops Q3 EPS by 7c; offers FY24 guidance

USANA Health Sciences Inc. (USNA) PT Lowered to $35 at DA Davidson

October 23, 2024 5:47 AM EDT

DA Davidson analyst Linda Bolton Weiser lowered the price target on USANA Health Sciences Inc. (NYSE: USNA) to $35.00 (from $38.00) while maintaining a Neutral rating.

The analyst comments "NEUTRAL-rated USNA reported a 3Q24 sales miss, but EPS of $0.56 beat consensus by $0.07 due to... More